Michael J. Lamson

Michael J. Lamson is the Vice President of Clinical Pharmacology and Pharmacokinetics at Nuventra Pharma Sciences. Michael has over twenty years of experience in the pharmaceutical industry, having previously worked as the Senior Director of Pharmacokinetics and Clinical Pharmacology at King Pharmaceuticals R&D / Pfizer and as an Associate Director / Sr. PK Scientist at Boehringer Ingelheim.

Lamson has extensive experience in designing and coordinating clinical pharmacology programs in support of US and global pharmaceutical registration activities. Michael has also authored numerous regulatory documents throughout their career. In their current role at Nuventra, Lamson is responsible for overseeing all aspects of the company's clinical pharmacology and pharmacokinetics activities. Michael is also involved in the design and execution of Nuventra's clinical studies.

Michael J. Lamson attended The University of Connecticut from 1986 to 1991, where they earned their Ph.D. in Biopharmaceutics.